Norcross, GA-based Guided Therapeutics has announced CE Mark approval of its LuViva Advanced Cervical Scan, which uses spectroscopy to detect early stage cervical disease. LuViva shines light at the cervix and uses spectroscopy to analyze the returned light, which allows the device to provide immediate results. Additionally, an initial clinical trial suggested that in addition to being less invasive, LuViva can detect cervical disease years earlier than traditional tests.
Press release: Guided Therapeutics Notified of CE Mark Approval for LuViva® Advanced Cervical Scan…
Product page: LuViva® Advanced Cervical Scan…